Laserfiche WebLink
<br />2 <br /> <br /> <br /> <br /> <br />II. SCHOOL’S RESPONSIBILITIES <br /> <br /> A. School will provide information to Agency concerning its curriculum and the <br />professional and academic credentials of its faculty for the students at Agency. School <br />will designate an appropriately qualified and credentialed faculty member to coordinate <br />and act as the Liaison with Agency. School will be responsible for instruction and <br />administration of the students’ academic education program. School will notify Agency in <br />writing of any change or proposed change of its Liaison. School will have the final <br />responsibility for grading students. <br /> <br /> B. School’s faculty will meet with the Agency clinical education Supervisor <br />Preceptors, if any, at the beginning and end of the clinical education program to discuss <br />and evaluate the clinical education program. These meetings will take place in person if <br />practicable, otherwise by telephone conference. School is responsible for arranging and <br />planning the meetings. <br /> <br /> C. School will provide the names and information pertaining to relevant <br />education and training for all students enrolled in the clinical education program at least <br />four weeks before the beginning date of the clinical education program. School is <br />responsible for supplying any additional information required by Agency as set forth in <br />this Agreement, prior to the arrival of students. School will notify Agency in writing of any <br />change or proposed change in a student’s status. <br /> <br /> D. School will obtain evidence of current immunizations against diphtheria, <br />tetanus, measles (rubeola), mumps, rubella (or a positive rubella titer), and of hepatitis B <br />immunity status, documented by a protective titer, for those students who will be in conta ct <br />with patients/clients. For each student born after 1956, School will maintain on file records <br />of positive titer or of post-1967 immunization for rubella and rubeola. At the time of <br />immunization, students with no history of exposure to chickenpox will be advised to get <br />an immune titer. School will require yearly PPD testing or follow-up as recommended if <br />the students are PPD-positive or have had BCG. School will provide information to <br />Agency regarding student status concerning the above requirements. <br /> <br /> E. School will assign to Agency only those students who have satisfactorily <br />completed the prerequisite didactic portion of the curriculum and who have evidence of <br />completion of a CPR course based on American Heart Association or American Red <br />Cross guidelines and related to the age group(s) with whom they will be working. <br /> <br /> F. School shall ask each student who may be placed in Agency to obtain <br />his/her criminal history background record from the Washington State Patrol, pursuant to <br />RCW 43.43.834 and RCW 43.43.838, to release a copy of that record to the School, and <br />to authorize the School to transmit that record or copy thereof to Agency. Before the start <br />of training, School will provide Agency with the names of any students who have failed to <br />provide the requested records, or who refuse to authorize the release of records to